Evolus (EOLS) Property, Plant & Equipment (Net) Growth (1y) (2019 - 2026)
Evolus (EOLS) Property, Plant & Equipment (Net) Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -18.34% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.19% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -0.59% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 41.67% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -7.68% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | -1.31% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 3.98% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 3.94% |
| 10 | Evolus | 550.51 Mn | 505.34 Mn | 57.18 Mn | 38.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.13% |
| Mar 31, 2026 | 63.95% |
| Dec 31, 2025 | 66.70% |
| Sep 30, 2025 | 121.74% |
| Jun 30, 2025 | 59.94% |
| Mar 31, 2025 | 55.84% |
| Dec 31, 2024 | 54.38% |
| Sep 30, 2024 | 8.64% |
| Jun 30, 2024 | -2.93% |
| Mar 31, 2024 | -19.54% |
| Dec 31, 2023 | -20.22% |
| Sep 30, 2023 | 13.18% |
| Jun 30, 2023 | 61.72% |
| Mar 31, 2023 | 99.16% |
| Dec 31, 2022 | 90.81% |
| Sep 30, 2022 | 77.88% |
| Jun 30, 2022 | 27.97% |
| Mar 31, 2022 | 7.07% |
| Dec 31, 2021 | 5.71% |
| Sep 30, 2021 | -22.32% |